Chennai Meenakshi Multispeciality Hospital Ltd vs Kwick Forensic Solutions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 36.4 as of 23 Oct 15:30 . The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 4.3 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Kwick Forensic Solutions Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 7.28 crore on March 2021 to ₹ 24.66 crore on March 2026 . This represents a CAGR of 22.55% over 6 yearsThe Market Cap of Kwick Forensic Solutions Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 8.7 crore as compare to the Mar '26 revenue of ₹ 10.05 crore. This represent the decline of -13.43% The revenue of Kwick Forensic Solutions Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0.46 crore as compare to the Mar '26 ebitda of ₹ 0.48 crore. This represent the decline of -4.17% The ebitda of Kwick Forensic Solutions Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ -0.38 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Kwick Forensic Solutions Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Kwick Forensic Solutions Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Chennai Meenakshi Multispeciality Hospital Ltd

Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology. The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.

About Kwick Forensic Solutions Ltd

Kwick Forensic Solutions Limited was initially incorporated as 'Kwick Soft Solutions Private Limited' as a Private Company on March 4, 2005 with the Registrar of Companies, Tamil Nadu.
Later, the name of the Company got changed from 'Kwick Soft Solutions Private Limited' to 'Kwick Integrated Forensic and Investigation Solutions Private Limited' on July 08, 2024 and again changed to 'Kwick Forensic Solutions Private Limited' on September 16, 2024.
Now, the Company has got status converted to Public Limited Company via fresh Certificate of Incorporation issued by the Central Processing Centre on April 29, 2025. Company provides end-to-end forensic products and services across four segments-Forensic Science & Physical Evidence Solutions, Mobile CSI Vehicles, Cyber & Digital Forensics, and DNA Forensics-together with a services line for liquor detection scanner with manpower support.

FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and null

Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Kwick Forensic Solutions Ltd?

Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 27 Cr while Market cap of Kwick Forensic Solutions Ltd is 405 Cr

What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Kwick Forensic Solutions Ltd?

The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Kwick Forensic Solutions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Kwick Forensic Solutions Ltd?

As of October 25, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹36.4. On the other hand, Kwick Forensic Solutions Ltd stock price is INR ₹188.95.

How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Kwick Forensic Solutions Ltd compare?

To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Kwick Forensic Solutions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.